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Abstract
Colorectal cancer (CRC) genome is unstable and different types of instabilities, such as chromosomal instability (CIN) and 
microsatellite instability (MSI) are thought to reflect distinct cancer initiating mechanisms. Although 85% of sporadic CRC 
reveal CIN, 15% reveal mismatch repair (MMR) malfunction and MSI, the hallmarks of Lynch syndrome with inherited 
heterozygous germline mutations in MMR genes. Our study was designed to comprehensively follow genome-wide 
expression changes and their implications during colon tumorigenesis. We conducted a long-term feeding experiment in 
the mouse to address expression changes arising in histologically normal colonic mucosa as putative cancer preceding 
events, and the effect of inherited predisposition (Mlh1+/−) and Western-style diet (WD) on those. During the 21-month 
experiment, carcinomas developed mainly in WD-fed mice and were evenly distributed between genotypes. Unexpectedly, 
the heterozygote (B6.129-Mlh1tm1Rak) mice did not show MSI in their CRCs. Instead, both wildtype and heterozygote CRC 
mice showed a distinct mRNA expression profile and shortage of several chromosomal segregation gene-specific transcripts 
(Mlh1, Bub1, Mis18a, Tpx2, Rad9a, Pms2, Cenpe, Ncapd3, Odf2 and Dclre1b) in their colon mucosa, as well as an increased 
mitotic activity and abundant numbers of unbalanced/atypical mitoses in tumours. Our genome-wide expression profiling 
experiment demonstrates that cancer preceding changes are already seen in histologically normal colon mucosa and that 
decreased expressions of Mlh1 and other chromosomal segregation genes may form a field-defect in mucosa, which trigger 
MMR-proficient, chromosomally unstable CRC.
Introduction
Colorectal cancer (CRC) is the third most common cancer 
and the fourth most common cause of cancer-related deaths 
worldwide. The incidence rates increase significantly with age 
and interactions between genetic and environmental factors, 
including diet, are suggested to play a critical role in its etiology 
(1,2). Cancer development always includes lack of genomic 
integrity in cells and different types of genomic instability, such 
as chromosomal instability (CIN) and microsatellite instability 
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(MIN, also called MSI) are thought to reflect distinct initiating 
mechanisms in cancer (3). Three different pathways leading to 
genomic instability in colon cancer have been described. Most 
CRCs represent CIN, where chromosomes fail to trigger the 
spindle assembly checkpoint (SAC) leading to aberrant chromo-
some segregation. In recent years, many new genes have been 
reported, whose mutations and expression changes disturb 
chromosomal stability causing aneuploidy and/or comprehen-
sive loss of heterozygosity (LOH) and alterations in chromosome 
structure (4,5). About 15% of sporadic CRCs and over 95% of CRCs 
in Lynch syndrome (LS), the most common inherited colon can-
cer syndrome, represent MSI caused by a defective DNA mis-
match repair (MMR) mechanism (6). MMR deficiency causes 
accumulation of point mutations in the genome and especially 
in short repeat sequences called microsatellites, and is thought 
to be the driver defect in MSI carcinomas (7). The third path-
way, CpG Island Methylator Phenotype (CIMP), characterized by 
global genome hypermethylation and tumour suppressor gene 
silencing, is seen in 20–30% of CRCs (6).
There are different ways to induce MMR malfunction and 
consequently lead to MSI. In sporadic tumours, the most com-
mon mechanism is the MLH1 (mutL homolog 1) promoter hyper-
methylation often associated with BRAF V600E mutation (8). 
Also, in CIMP tumours the MLH1 is often inactivated by promoter 
hypermethylation but usually caused by aging and environmen-
tal factors (9). In LS, the first mutation is inherited, mainly in 
MLH1 (40%), MSH2 (34%) or MSH6 (18%) (10) and generally fol-
lowed by LOH and somatic inactivation of the MMR gene (8). In 
LS, the second hit leading to MSI rarely happens through pro-
moter hypermethylation (11). The fact that inactivation of MLH1 
is associated with most MSI tumours irrespective of the inacti-
vating mechanism emphasizes MLH1 deficiency as a key defect 
shared by sporadic and inherited CRC.
Colon cancer research focuses mainly on tumour charac-
teristics, such as genomic instability, which can be utilized in 
treatment design. Recent findings have revealed that CIN and 
MSI pathways are not mutually exclusive (4,12), suggesting that 
also tumours with distinct features and instabilities may share 
initiative genomic aberrations while different tumour charac-
teristics reflect subsequent alterations during cancer develop-
ment. Since MLH1 deficiency seems to be a key defect shared 
by sporadic and inherited microsatellite unstable CRC, our aim 
was to follow how MLH1 would contribute to colon cancer devel-
opment. Here, we used a mouse model to study cancer preced-
ing expression changes in colon mucosa, Mlh1 phenotype in 
tumours and the effect of inherited predisposition (Mlh1+/−) and 
Western-style diet (WD) on those (13). We conducted a long-
term feeding experiment with either a healthy rodent diet AIN-
93G (AIN) or WD modified from AIN. WD was used to ensure the 
development of colon carcinomas, since it has previously been 
shown to cause CRCs in mice even without any predisposing 
mutation or carcinogen treatment (14–17). The mouse model 
provided a valuable tool to study the process of carcinogenesis 
from the earliest changes in colon mucosa until tumour devel-
opment and characterization. Moreover, the use of an animal 
model enabled to distinguish gene expression changes caused 
by different risk factors, such as age, inherited predisposition 
and diet and sort out the ones that signal carcinogenesis.
Materials and methods
Mice, experimental study and diets
Heterozygote B6.129-Mlh1tm1Rak mice (Mlh1+/−) strain 01XA2 (18) and the 
C57BL/6 strain were obtained from NCI-MMHCC; National Institutes of 
Health, Mouse Repository, NCI-Frederick, MD. Altogether 12 animals (equal 
numbers of sexes), the Mlh1+/− mice and their wild-type C57BL/6 mates, 
formed six breeder pairs which produced the mouse colony used in our 
study. Mice were genotyped (Figure 1C) using genomic DNA extracted from 
earmarks according to the protocol published in our previous work (19). The 
mice were bred and treated according to the study protocol approved by the 
National Animal Experiment Board in Finland (ESLH-2008-06502/Ym-23).
The Mlh1 heterozygote mice and their homozygote wild-type litter-
mates were divided into two dietary groups at the age of 5 weeks. The 
mice were fed with either healthy rodent control diet AIN-93G (20) or 
WD modified from AIN (Harlan Teklad, Madison, WI) (19) to resemble, on 
the nutritional level, the diet consumed in human Western population 
(high fat and energy content, low amounts of fiber, calcium and vitamin 
D3) (Supplementary Table 1) (19) Twelve mice per each group (Mlh1
+/+ AIN, 
Mlh1+/− AIN, Mlh1+/+ WD, Mlh1+/− WD) with equal representation of sexes, at 
time point (tp) 0 (5 weeks of age, Mlh1+/−, Mlh1+/+), tp1 (12 months of age), 
tp2 (18 months of age) and tp3 (21 months of age), 168 mice in total were 
sacrificed and sampled.
Collection of tumours and normal colon mucosa 
samples
All observed colon tumours were collected under dissecting microscope 
and preserved as FFPE blocks. If a tumour was large enough (3–5 mm in 
diameter), approximately half of it was embedded in O.C.T compound 
(VWR, Radnor, Pennsylvania) for cryo sampling. Histological studies, stain-
ings and the grading of neoplasias were carried out at The Finnish Centre 
for Laboratory Animal Pathology (FCLAP), University of Helsinki, Finland. 
The neoplasias were graded as hyperplasias, adenomas and carcinomas 
according to criteria based on consensus rodent intestinal cancer nomen-
clature (21), (Supplementary Table 2). Longitudinal pieces (excluding the 
previously harvested tumorous sections), representing approximately one 
third of the proximal mouse colon were collected for normal mucosa. The 
mucosa was separated from the underlying submucosa and muscula-
ture under a dissecting microscope and samples for RNA extraction were 
stored in RNAlater (Qiagen, Hilden, Germany) at −80°C (13).
Transcriptome analysis of normal mucosa
Transcriptome analysis was performed using RNA-sequencing method 
(RNA-seq). Total RNA was prepared from 0, 12 and 18 months old mice (14, 
40 and 40 mice, respectively) using the RNeasy Plus Kit (Qiagen) with an 
extra DNase treatment (Qiagen). The RNA concentration was measured by 
Qubit 1.0 (Thermo Fisher Scientific, Waltham, MA) and RNA integrity with 
the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Only 
high quality RNA (RNA integrity number RIN ≥ 8) qualified for expression 
analysis (13).
RNA-seq method followed the single-cell tagged reverse transcription 
(STRT) (22) protocol with modifications (23). Briefly, 10 ng of total RNA was 
converted to cDNA and amplified to form an Illumina-compatible library. 
In total, 25 PCR cycles were used, but as four base-pair unique molecular 
identifiers were applied, only the absolute number of unique reads were 
included in the subsequent analysis. The samples were sequenced on a 
total of six lanes of Illumina HiSeq2000, further processed to fastq files by 
Casava 1.8.2 (both Illumina, San Diego, CA). Quality control was performed 
using the STRTprep pipeline (https://github.com/shka/STRTprep) (23). The 
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processed reads were aligned by TopHat2 to the mouse RefSeq mm9 ref-
erence genome. STRT captures sequences at the 5′-end of poly(A)+ RNAs 
and the aligned reads therefore tend to be distributed close to the 5′-
end (start site) of genes. STRTprep counts only the aligned reads at the 
5′-untranslated region of protein-coding genes, or within the proximal 
(500 bp) upstream region (13).
Normalizing the RNA-seq data
STRTprep pipeline generated a read count matrix, with genes as rows 
and samples as columns. Different sample library sizes were normalized 
using DESeq-style normalization (24). Next shifted log transformation 
x xlog = +( )( )log 1  was done to generate more Gaussian like data and the 
ComBat program was used to filter batch effects. These preprocessing steps 
and alternative pipelines were evaluated by looking at the hierarchical clus-
tering of samples and by plotting quantiles of expression values for each 
sample (Supplementary Information, available at Carcinogenesis Online) (13).
Tests for differential gene expression
Since the analyzed data was not any more integer count values after 
ComBat normalization, we tested three t-test based methods, Voom-
Limma, Cyber-T and Shrinkage-T for analysis of differential gene expres-
sion. All these methods add a prior to variance estimate. Shrinkage-T 
is the only method here that allows also testing with unequal variance. 
This turned out to be important, as the genes with strongest separation 
between the sample groups had small variance in the analysed subset and 
medium variance among remaining samples.
The three methods were evaluated by viewing the separation of cancer 
samples from the remaining samples in the multidimensional Scaling (MDS) 
plots with top-k genes, which were selected using the evaluated statistic. 
Parameter k was varied from 25 to few hundreds. Shrink-T showed the best 
separation in the generated plots across all values of k. Each methods’ abil-
ity to find correlations with Gene Ontology classes was also tested. We used 
t-test scores from each method separately as an input to enrichment analysis 
tool called GSZ (Gene Set Z-score) (25). Shrink-T again generated strongest 
results. We therefore applied only Shrink-T in the subsequent analyses (13).
Visualization of sample differences
To detect similarities and differences between the samples, we used 
MDS that generates a small-dimensional visualisation from the 
multidimensional data while trying to preserve the pair-wise distances 
of samples from the multi-dimensional data. PlotMDS distributed in the 
Limma package was used as a basis of the analysis (26), although modified 
so that we were able to use any selected score to pick the genes that were 
used to calculate pair-wise distances (13).
The activity of Mlh1 was visualized with ComBat normalized data. 
Samples were grouped based on the sample types (genotype, diet and 
time-point) to highlight the sample differences.
Pathway analysis
To study the biological functions and pathways enriched among the top 
separating genes, we used QIAGEN’s Ingenuity Pathway Analysis (IPA 
Software 7.0, Qiagen). Here, we analysed both the top 100 and top 300 
genes, which were found to separate the normal mucosa expression pat-
terns in carcinoma mice from the others. The settings for a core analysis 
were as follows: ingenuity knowledge base (genes and endogenous chemi-
cals) with both direct and indirect relationships, default network inter-
action settings (include endogenous chemicals, 35 molecules per network 
and 25 networks per analysis). Data sources were used with stringent con-
fidence (experimentally observed and high predicted) and data obtained 
in all species was selected with a relaxed filter (13).
MSI and LOH analyses
The MSI status was analysed from all the seven carcinomas (two Mlh1+/+ 
WD, four Mlh1+/− WD and one Mlh1+/+ AIN mice, Table  1) from which a 
cryo-preserved sample was available, using four dinucleotide (D18Mit15, 
D14Mit15, D10Mit2, D7Mit91) and two mononucleotide (JH104, U12235) 
markers (27). Tumour DNA samples were extracted from the cryo-pre-
served colon carcinomas using laser micro-dissection for cutting (Zeiss 
PALM MicroBeam, Carl Zeiss Microscopy GmbH, Jena, Germany) and nor-
mal DNA control samples from the tails of the same mice with QIAamp 
DNA micro Kit, and DNeasy Blood & Tissue Kit (Qiagen), respectively. The 
genomic DNA was amplified with 6-FAM labeled primers in 11.1× PCR 
master mix (28) using the following PCR protocol: 1 min at 96°C, 30 cycles 
of 20 s at 96°C, 30 s at 62°C and 15 s at 70°C, and 7 min at 70°C. The frag-
ments were analysed with ABI3730xl capillary electrophoresis (Thermo 
Fisher Scientific) and visualized with PeakScanner v1.0 (Thermo Fisher 
Scientific) (13).
The four colon carcinomas found in the heterozygote Mlh1+/− mice, of 
which the cryo sample was available, were also studied for loss of Mlh1. 
Figure 1. Mlh1 protein expression and loss of heterozygosity analyses. (A) An example of a colon carcinoma showing positive Mlh1 expression analysed by immunohis-
tochemistry (mouse E402, tubular adenocarcinoma). (B) Four CRCs found in heterozygote Mlh1+/− mice showing that the normal Mlh1 allele (350 bp) was still present in 
tumours. (C) In Mlh1 heterozygote mice, one of the Mlh1 alleles is mutated by replacing the exon 2 with a neomycin cassette. Loss of Mlh1 heterozygosity was analysed 
using the genotyping primers M001, M002 and M003, which produce two different length fragments, 350 and 500 bp, that separate the normal (M001/M003) and the 
mutated allele (M001/M002), respectively.
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Loss of heterozygosity was analysed using the genotyping primers M001 
(TGT CAA TAG GCT GCC CTA GG), M002 (TGG AAG GAT TGG AGC TAC GG), 
and M003 (TTT TCA GTG CAG CCT ATG CTC), which produce two different 
length fragments, 350 and 500 bp, separating the normal (M001/M003) and 
the mutated allele (M001/M002), respectively (19) (Figure 1B, C). DNA was 
amplified with the 11.1× PCR master mix as described above and the frag-
ments were visualized on 1% SB agarose gel.
Immunohistochemical analysis of Mlh1 protein 
expression in carcinomas
Formalin-fixed, paraffin embedded cancer tissue blocks were studied for 
Mlh1 expression. The 4 µm thick sections were deparaffinized and rehy-
drated and heat induced antigen retrieval was performed with 10 mM cit-
rate buffer (pH 6). To detect Mlh1, the slides were incubated overnight at 
4°C with the rabbit monoclonal antibody ab92312 (1:1500) (clone EPR3894, 
Abcam, Cambridge, UK). Stainings were visualized using UltraVision 
Detection System anti-rabbit HRP/DAB (ThermoFisher Scientific, Waltham, 
MA) by manufacturer´s instructions. Analysis of staining patterns was 
conducted at The Finnish Centre for Laboratory Animal Pathology (13).
Analysis of mitoses in carcinomas
A Feulgen with Midori green background stain was used to visualise 
nuclear material and mitoses in six carcinoma samples (E249, E314, E329, 
E333, E338 and E347). The samples were deparaffinized and rinsed in 1 
M HCl. Mild acid hydrolysis was accomplished by using 60°C 1 M HCl 
and DNA was stained purple in Schiff´s reagent for 45 min. After several 
bisulfite washes the samples were counterstained briefly with 1% Midori 
light green, dehydrated through alcohol series to xylene and mounted 
with xylene based mounting media. The stained samples were analysed 
under light microscope (Zeiss Axio Imager.A2, Carl Zeiss Microscopy 
GmbH) and the mitoses in the malignant areas of carcinomas were com-
pared to mitoses in samples (E305, E311, E322, E323 and E346) from healthy 
mice (13).
Statistical analysis
Differential expression analysis (DEA) used modified t-tests (Limma, 
cyber-T and shrinkage-T). With Limma and cyber-T, we used their own 
P-value estimates. Shrinkage-T does not provide a P-value estimate, which 
were estimated by re-calculating Shrinkage-T with 1000 permutations for 
each gene separately. Normal distribution was fitted to the permutations 
and a one-tailed P-value was obtained from the cumulative distribution. 
Multiple testing correction was performed using false discovery rate. 
Importantly, we used DEA mainly to order the genes to most differentially 
regulated genes. All analysis was performed within the R-environment. 
Pathway enrichment analysis was done using IPA which uses Fisher’s 
exact test to analyse over-representation of genes from the analysed gene 
groups. Here, multiple testing correction was done using the Benjamin–
Hochberg method (13).
Results
Carcinomas developed mainly and earlier in WD 
fed mice
The feeding study was done with offspring produced by crossing 
two isogenic strains, the heterozygote Mlh1+/− (B6.129-Mlh1tm1Rak) 
Table 1. Characteristics of mice and their tumours
ID Age Genotype Diet Gender
Tumour characteristics
Histopathology MSI LOH Mlh1 expression
E249 12 Mlh1+/+ WD M Tubular ac NA NA Positive
E314 18 Mlh1+/+ WD M Mucinous ac NA NA Positive
E329 18 Mlh1+/+ AIN F Tubulovillous ac NA NA Positive
E333 18 Mlh1+/+ WD F Tubular ac NA NA Positive
E338 18 Mlh1+/− WD F Tubular ac MSS — Positive
E347 18 Mlh1+/− WD F Serrated ac MSS — Positive
E402 21 Mlh1+/+ WD F Tubular ac MSS NA Positive
E409 21 Mlh1+/+ WD M Mucinous ac NA NA Positive
E410 21 Mlh1+/+ WD M Tubular ac NA NA Positive
E421 21 Mlh1+/+ AIN F Tubular ac MSS NA Positive
E437 21 Mlh1+/− WD M Mucinous ac MSS — Positive
E444 21 Mlh1+/− WD F Mucinous ac MSS — Positive
E453 21 Mlh1+/− AIN F Tubulovillous ac NA NA Positive
E214 12 Mlh1+/+ WD F Adenoma NA NA NA
E244 12 Mlh1+/− WD F Adenoma NA NA NA
E246 12 Mlh1+/− AIN F Adenoma NA NA NA
E321 18 Mlh1+/− WD F Serrated adenoma NA NA NA
E337 18 Mlh1+/+ WD F Adenoma NA NA NA
E402 21 Mlh1+/+ WD F Adenoma NA NA NA
E411 21 Mlh1+/+ WD F Adenoma NA NA NA
E416 21 Mlh1+/+ WD M Adenoma NA NA NA
E446 21 Mlh1+/− WD F Adenoma NA NA NA
E448 21 Mlh1+/− AIN F Adenoma NA NA NA
E217 12 Mlh1+/+ WD M Hyperplasia NA NA NA
E307 18 Mlh1+/− WD M Hyperplasia NA NA NA
E328 18 Mlh1+/− AIN F Hyperplasia NA NA NA
E405 21 Mlh1+/+ WD F Serrated hyperplasia NA NA NA
E408 21 Mlh1+/− AIN F Hyperplasia NA NA NA
E409 21 Mlh1+/+ WD M Hyperplasia NA NA NA
E410 21 Mlh1+/+ WD M Hyperplasia NA NA NA
E430 21 Mlh1+/− AIN M Hyperplasia NA NA NA
E433 21 Mlh1+/+ AIN F Hyperplasia NA NA NA
E454 21 Mlh1+/− WD F Hyperplasia NA NA NA
ac, adenocarcinoma; AIN, AIN-93G diet; F, female; M, male; NA, not analysed; WD, Western-style diet.
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and the wild-type Mlh1+/+ (C57BL/6) mice, and selecting an equal 
number of both genotypes to the study. Half of the mice fed WD 
and half the control diet, AIN-93G. In all 168 mice, 24 mice at 
time point 0 and 48 mice at time points 12, 18 and 21 months, 
were operated. Approximately 80% of all colon tumours, 10 out 
of 13 colon adenocarcinomas and 14 out of 20 adenomas and 
hyperplasias, developed in WD-fed mice (Table 1) (13).
At time points 12, 18 and 21 months, 80, 78 and 64% of all 
tumours and 100, 80 and 72% of CRCs were found in WD-fed 
mice, respectively. The overall number of colon tumours 
increased significantly with time (Supplementary Figure  1), 
being 5 at 12 months (one adenocarcinoma, two adenomas, one 
hyperplasia), 9 at 18  months (five adenocarcinomas, two ade-
nomas, two hyperplasias) and 19 at the 21 months time point 
(seven adenocarcinomas, five adenomas, seven hyperplasias). 
Tumours were approximately evenly distributed between dif-
ferent genotypes since heterozygote Mlh1+/− mice showed 0, 40 
and 43% of carcinomas and 50, 75 and 42% of adenomas and 
hyperplasias at different time points (Table 1). All the 13 carci-
nomas were found in the proximal part of colon and the major-
ity of them were either tubular (54%) or mucinous (31%), two 
were tubulovillous and one carcinoma had serrated histology 
(Supplementary Table  2, Supplementary Figure  2, available at 
Carcinogenesis Online).
Mlh1 mutation carriers did not show MSI, LOH and 
loss of MMR protein in tumours
To check for the typical LS characteristics, seven carcinomas 
found in 18 and 21 months old mice, four in the Mlh1+/− mice 
(E338, E347, E437, E444) and three in the Mlh1+/+ mice (E402, E410, 
E421), were analysed for MSI status and all the 13 carcinomas for 
Mlh1 expression. Surprisingly, all CRCs showed Mlh1 expression 
(Figure 1A), indicating that irrespective of the inherited muta-
tion in one Mlh1 allele in the heterozygote mice, the normal 
allele was still present in the tumours. The presence of the nor-
mal allele was further confirmed with LOH study in all the four 
Mlh1+/− carcinomas (Figure  1B). To study whether the detected 
Mlh1 protein was functional and MMR proficient, we analysed 
the stability of six polymorphic microsatellite regions in the 
mouse genome. The markers and their amplified fragment sizes 
were as follows: D14Mit15 (148  bp, 150  bp), D18Mit15 (151  bp, 
157 bp), D7Mit91 (139 bp, 147 bp), D10Mit2 (117 bp, 122 bp), JH104 
(178  bp, 181  bp) and U12235 (79  bp, 83  bp). Altogether six out 
of seven CRCs were studied (E410 could not be amplified) and 
shown to be microsatellite stable, since no differences in the 
fragment lengths were observed between the tumour and cor-
responding normal DNA (Supplementary Figure 3, available at 
Carcinogenesis Online) (13).
Mlh1 RNA expression was significantly decreased in 
normal mucosa of CRC mice
After finding that irrespective of the mouse genotype, func-
tional Mlh1 was still expressed in carcinomas, our interest was 
to look for potential early drivers of tumorigenesis on a genome-
wide scale. Altogether 71 out of 80 normal colon mucosa sam-
ples operated from 12- and 18-month old mice were qualified 
for genome-wide transcriptome analysis. Analysis was done 
with RNAseq using the single-cell tagged reverse transcrip-
tion method (STRT) (23,29). The 21-month old mice were left 
out from the RNAseq study due to many health problems most 
probably because of their old age. Altogether 12 216 expressed 
transcripts were identified in the samples. First, we analyzed 
the Mlh1 gene expression levels from the STRT data (Figure 2). 
In our previous study (19), we showed that in the beginning of 
the feeding experiment (at time point 0), the Mlh1 heterozygote 
mice showed exactly 50% lower Mlh1 expression than the Mlh1+/+ 
mice. Contrary to varying Mlh1 expression levels in mice in gen-
eral, 5/6 mice (E249, E314, E329, E333, E338) who developed car-
cinoma showed remarkably low Mlh1 expression in their normal 
colon mucosa (P = 0.03) (Figure 2) (13). The mouse E347 whose 
carcinoma had serrated histology had, however, higher Mlh1 
expression level as non-carcinoma mice on average (Table  1; 
Figure 2).
Expression profiles in normal mucosa formed a 
distinct cluster for CRC mice
After finding that carcinoma mice had extremely low levels 
of Mlh1 transcripts in their mucosa, we next compared their 
genome-wide expression profiles with profiles of all other 12 
and 18 months old mice. The normal mucosa expression pro-
files of the six CRC mice were strikingly different from the pro-
files of the other mice and formed a distinct cluster as visualized 
by an MDS plot created with the 100 most altered/differentially 
regulated genes (Figure  3, Supplementary Table  3, available at 
Carcinogenesis Online). Altogether 86% of the top 300 differen-
tially regulated genes in CRC mice were down-regulated and 
14% were up-regulated (Supplementary Table  3, available at 
Carcinogenesis Online) (13).
Pathway analysis and shortage of chromosomal 
segregation gene-specific transcripts suggest 
problems in cell cycle regulation and mitosis
To further understand the biological functions and pathways 
enriched among the top separating genes in CRC mice, the 
expression data were analysed with Ingenuity Pathway Analysis. 
According to Ingenuity Pathway Analysis, chromosome segrega-
tion (P = 2.92 × 10–5), aneuploidy of fibroblasts (P = 5.31 × 10–4), 
checkpoint control (P = 1.10 × 10–4), DNA replication checkpoint 
(P = 1.88 × 10–4) and morphology of mitotic spindle (P = 6.45 × 10–5) 
were among the most affected biological functions. In network 
analysis, the most affected molecular and cellular functions 
included cell cycle (P = 9.24 × 10–5), cellular assembly and organ-
ization (P  =  9.24  ×  10–5), DNA replication, recombination and 
repair (P = 9.24 × 10–5), cell death and survival (P = 7.30 × 10–5) and 
cellular growth and proliferation (P = 3.07 × 10–3) (Supplementary 
Table  4, available at Carcinogenesis Online). The analysis was 
also repeated with different RNA-seq data preprocessing (all 
mouse samples without ComBat normalization, Supplementary 
Table  4, available at Carcinogenesis Online). These results con-
firmed our findings on chromosome segregation (P = 1.03 × 10–5), 
aneuploidy of fibroblasts (P = 4.57 × 10–4) and checkpoint control 
(P = 4.29 × 10–4) (13).
The Ingenuity Pathway Analysis results strongly indicated 
that there are severe problems in cell cycle regulation and mitosis 
already in colon mucosa. In the six mice who developed carcin-
oma up to 18 months, the most altered/differentially expressed 
genes that pointed to chromosome segregation and SAC were 
Bub1 (BUB1, mitotic checkpoint serine/threonine kinase), Mis18a 
(MIS18 kinetochore protein A), Tpx2 (TPX2 microtubule associ-
ated), Rad9a (RAD9 checkpoint clamp component A), Pms2 (post-
meiotic segregation increased 2), Mlh1 (mutL homolog 1, along 
with MMR function also triggers checkpoint activation), Cenpe 
(centromere protein E), Ncapd3 (non-SMC condensing II complex 
subunit D3), Odf2 (outer dens fiber of sperm tails 2) and Dclre1b 
(DNA cross-link repair 1B). Five of these 10 genes, Bub1, Mis18a, 
Tpx2, Rad9a and Pms2, were strongly down regulated in all of 
the six carcinoma mice (Figure 4). Mlh1, Cenpe, Ncapd3, Odf2 and 
Dclre1b showed variable level of expression in two CRC mice 
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(E347 and E249). In E249, Mlh1 and Dclr1b showed approximately 
50% down regulation when compared to the average expression 
level in non-carcinoma mice (Figure 4). In E347, whose carcin-
oma was histologically different from the others and showed 
typical serrated phenotype, Cenpe, Ncapd3 and Odf2 expression 
levels were equal and Mlh1 expression level higher than in the 
non-carcinoma mice. Importantly, among all the 74 mice that 
did not develop colon carcinoma up to 18  months, only two 
mice, E325 and E332, showed similar low expression of all the 
10 genes (Figure 4). Although, no colonic tumours were found 
in those mice, E325 had bloody feces and anemia, suggesting 
undefined mucosal pathology (13).
Abnormal mitoses and CIN in carcinomas
Undisturbed mitosis is a central requirement of the normal cell 
cycle and division. In cancer cells, mitoses are often aberrant, 





















Figure 3. Genome wide expression profiles in normal colon mucosa. An MDS plot created with the 100 most differentially expressed genes between CRC (green) mice 
and mice without cancer (black). The expression profiles of the six mice which developed carcinoma up to 18 months of age form a distinct cluster in the plot.
Figure 2. The Mlh1 mRNA expression in normal mucosa. The Mlh1 gene expression levels detected in individual mice at different time points, genotypes and diet 
groups, show that five out of six carcinoma mice (red triangle) show very low Mlh1 expression. Non-carcinoma mice E325 and E332 are shown with black crosses.
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showing aneuploidy caused by unequal segregation of chromo-
somes and/or structural changes in chromosomes, both of which 
lead to CIN. To validate the RNA sequencing results, which sug-
gested impaired cell cycle regulation and mitosis in CRC mice, all 
the 13 carcinomas were stained with feulgen and analyzed for 
mitotic aberrations. Although all the carcinomas were well-dif-
ferentiated early cancers with limited submucosal invasion and 
relatively lenient cytological changes, they exhibited increased 
mitotic activity and abundant numbers of unbalanced/atypical 
mitoses in contrast to normal tissue samples (Figure 5) (13).
Discussion
The instability status and other characteristics of colon tumours 
have been used to define the mechanisms behind colon can-
cer formation (3). Our present genome-wide expression profil-
ing experiment demonstrates that cancer preceding changes 
occur and can be detected already in normal colon mucosa. We 
show that these changes may form a field-defect in histologi-
cally normal mucosa and trigger MMR-proficient, chromosom-
ally unstable CRC both in Mlh1+/+ and Mlh1+/− mice.
Figure 4. The expression levels of 10 chromosomal segregation-specific genes in colon mucosa. The mRNA expression levels (gene expression values after ComBat 
processing) are described as (A) a line chart and as (B) expression values in the carcinoma mice (E249, E314, E329, E333, E338, E347), two mice with similar expression 
profiles with CRC mice (E325 and E332), and as the average levels of mice without cancer, including mice E325 and E332.
Figure 5. Abnormal mitoses in mouse colon carcinomas. Representative pictures of abnormal mitoses (arrows) in (A) serrated adenocarcinoma (mouse E347) and (B) 
tubular adenocarcinoma (mouse E333), and a normal mitosis (arrow head). 
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One common event linked to both sporadic and inherited 
MSI cancers is the inactivation of MLH1, although the inacti-
vation mechanism varies from genetic mutations in LS to epi-
genetic silencing in sporadic CRC (7,30). Our mouse study was 
designed to comprehensively clarify the role of Mlh1 expression 
during colon tumorigenesis and the effects of genetic predis-
position and other risk factors such as WD and aging on it. Mlh1 
protein expression was studied in colon tumours and Mlh1 gene 
expression in histologically normal mucosa. Approximately 
70% of all tumours and 80% of colon carcinomas developed in 
WD-fed mice indicating a strong diet effect on cancer predis-
position. 33 % of CRCs and 75% of adenomas and hyperplasias 
found in mice up to 18 months of age was found in Mlh1+/− mice. 
Surprisingly, Mlh1 protein was present and there was no MSI 
in their cancers. Genome-wide expression profiling of histologi-
cally normal mucosa however showed that 5/6 mice who devel-
oped CRC up to 18 months had significantly decreased mucosal 
Mlh1 RNA expression. Only in the carcinoma mouse E347 the 
Mlh1 expression level was higher than the average level of 65 
mice without cancer.
Low Mlh1 expression, although a prominent signal, seemed 
not to be an absolute requirement or sufficient alone to cause 
colon cancer since several mice without CRC had low Mlh1 
expression as well. In order to identify other genes and path-
ways involved in CRC development, we compared the genome 
wide expression profiles in the six CRC mice with the profiles of 
65 mice without CRC (13). Remarkably, the expression profiles of 
CRC mice formed a clearly distinct cluster (Figure 3), indicating 
a field-defect in normal colon mucosa (31,32). By network ana-
lysis of top 100 CRC mice separating genes, Mlh1 expression in 
normal mucosa from CRC mice was found to be low together 
with significant down regulation of several cancer related genes 
and pathways (Supplementary Table 3 and Tables 4, available at 
Carcinogenesis Online) and especially of chromosomal segregation 
genes, Bub1, Mis18a, Tpx2, Rad9a, Pms2, Cenpe, Ncapd3, Odf2 and 
Dclre1b. Only two (E325 and E332) of the 65 mice without cancer 
shared the expression profile of the CRC mice related to chromo-
somal segregation (Figure 4). Although no colonic tumours were 
found in those mice, carcinogenesis might been happening in 
their mucosa. For example, E325 had bloody feces and anemia 
suggesting pathological problems in mucosa. Differing from 
the other CRC mice, E347, which did not show decrease in Mlh1 
expression, showed decrease only in the expressions of Bub1, 
Mis18a, Tpx2, Rad9a, Pms2 and Dclre1b, suggesting their remark-
able importance in serrated carcinogenesis. Furthermore, in the 
mouse E249 the Mlh1 and Dclre1b genes showed approximately 
50% lower expression than was detected in the non-carcinoma 
mice on average. Here, the milder decrease may reflect young 
age of onset.
During cell division the SAC, which is the major target of 
mitotic alterations, maintains the genome stability by delay-
ing cell division until all chromosomes are accurately aligned 
in the spindle (33). Aberrant expression of mitotic genes leads 
to mitotic abnormalities including centrosome defects and 
improper spindle checkpoint leading to CIN (34) and tumour 
formation in multiple tissues including colon (35). In this study, 
the mRNA expression was significantly decreased in five SAC 
associated genes, Mlh1, Bub1, Rad9a, Dclre1b and Cenpe. Of those, 
Bub1 is a major player and activator in SAC and its haploinsuf-
ficiency (heterozygosity) is known to be responsible for chromo-
some segregation defects and aneuploidy (35). During mitosis, 
Bub1 is required for the recruitment of other checkpoint and 
motor proteins, such as Cenpe, to a kinetochore (36). There is 
evidence suggesting that inaccurate chromosome segregation 
with causal implication of Bub1 deficiency drives tumorigen-
esis through tumour-suppressor gene LOH (37), perfectly in 
line with our findings that the majority of the carcinoma mice 
distinguishing genes were tumour suppressor genes, which 
were down regulated (Supplementary Table  3, available at 
Carcinogenesis Online). Cenpe, a kinesin-like motor protein which 
is an efficient stabilizer of microtubule capture at kinetochores 
and hence essential for metaphase chromosome alignment 
(38), was strongly down regulated in the mice with carcinoma. 
While it plays an important role in the movement of chromo-
somes toward the metaphase plate during mitosis, it is also 
necessary for the mitotic checkpoint signal at the kinetochore 
to prevent chromosome loss (39). Dclre1b has a central role in 
telomere maintenance and protection during S-phase through 
its 5′–3′ exonuclease activity. Moreover, in case of spindle stress, 
Dclre1b like Bub1 is involved in prophase checkpoint (40,41). 
RAD9A, a component of the 9-1-1 cell cycle checkpoint response 
complex, plays a major role in DNA repair and participates in 
multiple cell cycle checkpoints and apoptosis and its aberrant 
expression has been linked to tumorigenesis of multiple tissues 
(42). Interestingly, Rad9 also physically interacts with the MMR 
protein MLH1 (43). The MMR mechanism is so essential for nor-
mal cell function that it may explain why even a small amount 
of MLH1 appears to be sufficient for MMR function, whereas its 
checkpoint activation role seems to require a full complement 
of the protein (44). It has been argued that the MLH1 heterozy-
gosity/haploinsufficiency may drive the development of cancer 
by accumulation of insertion/deletion mutations in other gate-
keeper genes prior to MSI (45). Indeed, cells with diminished 
amount of MLH1 protein may still be MMR proficient, although 
they show defects in DNA damage signalling (44). Consequently, 
the damaged cells may not activate cell cycle checkpoints and 
enter apoptosis. Our observation that low mRNA expression of 
Mlh1 in carcinoma mice together with down regulation of sev-
eral other genes related to chromosome segregation and check-
point control supports the proposition that already decreased 
amount of Mlh1, when MMR is still functional, may have an 
important role in tumorigenesis (13).
Low expression of Tpx2, Mis18a, Ncapd3 and Odf2 reflects 
problems in formation of the nuclear spindle and chromo-
some segregation. Tpx2, Ncpd3 and Odf2, a general scaffolding 
protein (46), are all involved in microtubules related pro-
cesses in spindle formation.Tpx2 plays a role in microtubule 
organization and is involved in centrosome maturation 
(47). In fact, TPX2-depleted cells fail to form proper mitotic 
spindles (48). Recent findings suggest that TPX2 also plays 
an important role in promoting colon tumorigenesis (49). In 
this study results support a driver role for Tpx2, since it was 
strongly down regulated in colon mucosa in all carcinoma 
mice. Ncapd3 functions in the condensin II complex and is 
needed to establish the chromosomal architecture necessary 
for proper spindle assembly and chromosome segregation. 
Chromosome condensation and resolution are compro-
mised when condensin is depleted (50). The MIS18 complex 
accumulates at the centromere during anaphase to early G1 
phase, slightly ahead of the histone H3 variant CENPA and 
is an absolute requirement for the localization of CENPA at 
centromeres. Importantly, Mis18a knockout causes severe 
chromosomal missegregation, lack of CENPA and ultimately 
cell death (51). Here, along with Mis18a, Cenpa was signifi-
cantly down regulated in the normal colon mucosa of the 
CRC mice (Supplementary Table 3, available at Carcinogenesis 
Online) supporting the finding of improper chromosome 
segregation.
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Our RNA sequencing results suggest that cancer preceding 
changes occur already in histologically normal mucosa and 
trigger MMR-proficient chromosomally unstable CRC. Problems 
in cell cycle regulation and mitosis were confirmed by tumour 
analysis, which showed increased mitotic activity and abun-
dant numbers of atypical mitoses in carcinomas. Altogether 71 
mice were included in genome-wide expression profiling and 
only two of the 65 mice without cancer shared the expression 
profile of the CRC mice related to chromosomal segregation, 
indicating that the aberrant expression of this gene set could be 
used as signalling carcinogenesis in colon mucosa. In addition, 
the finding of unexpected tumour phenotypes in Mlh1+/− mice 
implies that stable microsatellites and normal MLH1 expression 
in human tumours may not necessarily exclude inherited MLH1 
deficiency.
Supplementary material
Supplementary data can be found at Carcinogenesis online.
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